TNFRSF11B and acute lymphoblastic leukemia: Several studies have evaluated RANKL and OPG levels and the RANKL/OPG ratio in different pediatric diseases [19,25,26,32,33], but few studies have evaluated changes in bone health parameters in patients with ALL during treatment and without any intervention.